CTLA4 and cancer: Immunotherapies are promising treatments in cancer, aiming to activate the immune system to combat cancer cells, often by blocking immune checkpoint molecules such as PD1, PD-L1, and cytotoxic T lymphocyte antigen 4 (CTLA4) [34].